Navigation Links
ReBuilder Medical Technologies, Inc. Announces Unique Arthritic Pain Accessory

CHARLES TOWN, W.Va., Sept. 2 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) a provider of electronic treatments for the pain resulting from peripheral neuropathy and Peripheral Artery Disease today announced that it has released a new way to deliver the impulses of the ReBuilder for pain.


Physicians all over the U.S. are now using the ReBuilder as their first choice for the treatment of leg pain. Pain can be caused by many things, including Arthritis. Many of them are not registered with Medicare so that they can provide the ReBuilder to their patients with little or no out of pocket cost to the patient.

"While the ReBuilder has a 20 year proven track record for the treatment of chronic hand pain from neuropathy," said David Phillips, Ph.D. CEO., "some patients have used it successfully to treat their pain that originated from arthritis."

Additionally, Dr. Phillips reports: "This new way to administer the ReBuilder's signals is with a special conductive glove that replaces the common electrodes that have been used in the past."

Finally, Dr. Phillips told reporters today: "Now a patient with pain from arthritis can put on these form fitting gloves, turn on his ReBuilder, read his morning paper, and at the end of the 10 minute session he can feel the relief and can go about his normal activities symptom free. Now that Medicare covers the ReBuilder for pain, we expect another jump in sales."

Inquiries can be made at

Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.

SOURCE ReBuilder Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ReBuilder Medical Technologies, Inc.s Dr. Phillips to Speak to Ohio Investment Group
2. ReBuilder Medical Technologies, Inc. Announces Negotiations with National Medicare Provider
3. ReBuilder Medical Technologies, Inc. Announces Second Quarter 2009 Profits up 100%
4. ReBuilder Medical Technologies, Inc. Announces New York Marketing Agreement
5. ReBuilder Medical Technologies, Inc. Announces First Quarter 2009 is Profitable
6. ReBuilder Medical Technologies, Inc. to Change Name to American Med Tech
7. ReBuilder Medical Technologies, Inc. (RBRM) Announces Sales Increase In Jan. 09
8. ReBuilder Medical (RBRM) Neuropathy Market Doubles to $5 Billion
9. ReBuilder Medical Technologies, Inc. Appears Recession Proof
10. ReBuilder Medical Technologies, Inc. Says No to OTC - Rather Wait for NASDAQ
11. ReBuilder Medical Technologies, Inc. Seeks a Bigger and More Credible Equity Market - NASDAQ, here we come!
Post Your Comments:
(Date:11/25/2015)... San Mateo, CA (PRWEB) , ... November 25, 2015 , ... ... $15,000 in prizes were awarded to winners of the Create Real Impact awards. ... and creative expression to help stem the tide of distracted and reckless driving, the ...
(Date:11/24/2015)... ... November 24, 2015 , ... Dr. Todd S. Afferica, a ... services to many of his patients. Dr. Afferica now uses the BIOLASE WaterLase iPlus ... amount of time the doctor uses other traditional cutting tools, such as the scalpel ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... launched their Black Friday sale a week early, offering 40% off select bras ... the intimate apparel industry through both mobile fit technology and the latest fashion, ...
(Date:11/24/2015)... IL (PRWEB) , ... November 24, 2015 , ... ... are national leaders when it comes to several aspects of orthopedic care. They ... joint replacements, orthopedic surgeries and general orthopedic care. , Becker's Hospital Review ...
(Date:11/24/2015)... ... November 24, 2015 , ... Brillouin Energy Corp. Congress ... the developer of renewable energy technologies capable of producing commercially useful amounts of ... that its WET™ and HHT™ Boiler System reactor core modules were presented to ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ ... "Company") (NYSE: MR ), a ... medical devices worldwide, today announced that ... general meeting of shareholders at the ... Grand Century, 193 Prince Edward West Road, ...
(Date:11/25/2015)... Pennsylvania , November 25, 2015 - ... Continuing Medical Education (CME) --> ... Continuing Medical Education (CME) --> ... Care Continuing Medical Education (CME) ... medical information products and services, will feature latest diagnostic imaging textbooks ...
(Date:11/25/2015)... , Frankreich, November 25, 2015 ... heute bekanntgegeben, dass sie eine Lizenz für das Patent ... Poxel, CNRS, UCBL und ENS-Lyon innehaben, an Enyo Pharma ... von FUI AAP8 ins Leben gerufenen und von Edelris ... wurde FXR als ein Behandlungsziel für HBV identifiziert, und ...
Breaking Medicine Technology: